These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7949157)

  • 1. CD30 antigen and cellular biology of Reed-Sternberg cells.
    Pizzolo G; Vinante F; Chilosi M; Romagnani S; Del Prete G
    Blood; 1994 Dec; 84(11):3983-4. PubMed ID: 7949157
    [No Abstract]   [Full Text] [Related]  

  • 2. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 expression in L&H cells of Hodgkin's disease, nodular lymphocyte predominant type.
    Ranjan P; Naresh KN
    Histopathology; 2003 Apr; 42(4):406-7. PubMed ID: 12653955
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells.
    Heuser C; Diehl V; Abken H; Hombach A
    Int J Cancer; 2003 Sep; 106(4):545-552. PubMed ID: 12845650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological basis of Hodgkin's lymphoma.
    Horie R; Watanabe T
    Drug News Perspect; 2003 Dec; 16(10):649-56. PubMed ID: 14747844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omit iodine and CD30 will shine: a simple technical procedure to demonstrate the CD30 antigen on B5-fixed material.
    Facchetti F; Alebardi O; Vermi W
    Am J Surg Pathol; 2000 Feb; 24(2):320-2. PubMed ID: 10680909
    [No Abstract]   [Full Text] [Related]  

  • 7. Hodgkin's lymphoma and CD30 signal transduction.
    Horie R; Higashihara M; Watanabe T
    Int J Hematol; 2003 Jan; 77(1):37-47. PubMed ID: 12568298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells.
    Ohshima K; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kawasaki C; Haraoka S; Kikuchi M
    Int J Cancer; 2002 Apr; 98(4):567-72. PubMed ID: 11920617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease: biology and origin of Hodgkin and Reed-Sternberg cells.
    Stein HS; Hummel M
    Cancer Treat Rev; 1999 Jun; 25(3):161-8. PubMed ID: 10425258
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor.
    Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA
    Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 is involved in inhibition of T-cell proliferation by Hodgkin's Reed-Sternberg cells.
    Su CC; Chiu HH; Chang CC; Chen JC; Hsu SM
    Cancer Res; 2004 Mar; 64(6):2148-52. PubMed ID: 15026356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment.
    Rinaldi I
    Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30, Th2 cytokines and HIV infection: a complex and fascinating link.
    Del Prete G; Maggi E; Pizzolo G; Romagnani S
    Immunol Today; 1995 Feb; 16(2):76-80. PubMed ID: 7888070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha.
    Karube K; Ohshima K; Suzumiya J; Kawano R; Kikuchi M; Harada M
    Ann Oncol; 2006 Jan; 17(1):110-6. PubMed ID: 16291580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.
    Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E
    J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease.
    Xerri L; Birg F; Guigou V; Bouabdallah R; Poizot-Martin I; Hassoun J
    Int J Cancer; 1992 Mar; 50(5):689-93. PubMed ID: 1312061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas.
    Rodig SJ; Savage KJ; Nguyen V; Pinkus GS; Shipp MA; Aster JC; Kutok JL
    Am J Surg Pathol; 2005 Feb; 29(2):196-203. PubMed ID: 15644776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical chromosome aberrations in CD30+ cells of Hodgkin's disease: truth or FICTION.
    Younes A
    Blood; 1996 May; 87(10):4479-80. PubMed ID: 8639811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.